These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18197467)

  • 1. Extensions to the visual predictive check to facilitate model performance evaluation.
    Post TM; Freijer JI; Ploeger BA; Danhof M
    J Pharmacokinet Pharmacodyn; 2008 Apr; 35(2):185-202. PubMed ID: 18197467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized visual predictive check versus visual predictive check for model evaluation.
    Wang DD; Zhang S
    J Clin Pharmacol; 2012 Jan; 52(1):39-54. PubMed ID: 21257797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual Predictive Check in Models with Time-Varying Input Function.
    Largajolli A; Bertoldo A; Campioni M; Cobelli C
    AAPS J; 2015 Nov; 17(6):1455-63. PubMed ID: 26265094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].
    Ren YP; Deng CH; Wang XP; Zhou TY; Lu W
    Yao Xue Xue Bao; 2011 Sep; 46(9):1123-31. PubMed ID: 22121786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.
    Bergstrand M; Hooker AC; Wallin JE; Karlsson MO
    AAPS J; 2011 Jun; 13(2):143-51. PubMed ID: 21302010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
    Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
    Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.
    Brendel K; Dartois C; Comets E; Lemenuel-Diot A; Laveille C; Tranchand B; Girard P; Laffont CM; Mentré F
    Clin Pharmacokinet; 2007; 46(3):221-34. PubMed ID: 17328581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
    Comets E; Brendel K; Mentré F
    Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap.
    Dosne AG; Niebecker R; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):597-608. PubMed ID: 27730481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a hazard-based visual predictive check to evaluate parametric hazard models.
    Huh Y; Hutmacher MM
    J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):57-71. PubMed ID: 26563504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the dose-response relationship: the fair share of pharmacokinetic and pharmacodynamic information.
    González-Sales M; Nekka F; Tanguay M; Tremblay PO; Li J
    Br J Clin Pharmacol; 2017 Jun; 83(6):1240-1251. PubMed ID: 28035697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.
    Thai HT; Mentré F; Holford NH; Veyrat-Follet C; Comets E
    J Pharmacokinet Pharmacodyn; 2014 Feb; 41(1):15-33. PubMed ID: 24317870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
    Han K; Bies R; Johnson H; Capitano B; Venkataramanan R
    Clin Pharmacokinet; 2011 Mar; 50(3):201-14. PubMed ID: 21294597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
    Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
    Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptin.
    Langford O; Aronson JK; van Valkenhoef G; Stevens RJ
    Stat Methods Med Res; 2018 Feb; 27(2):564-578. PubMed ID: 26994216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.
    Tornøe CW; Overgaard RV; Agersø H; Nielsen HA; Madsen H; Jonsson EN
    Pharm Res; 2005 Aug; 22(8):1247-58. PubMed ID: 16078134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handling data below the limit of quantification in mixed effect models.
    Bergstrand M; Karlsson MO
    AAPS J; 2009 Jun; 11(2):371-80. PubMed ID: 19452283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.
    Wu X; Xie H; Lin W; Yang T; Li N; Lin S; Yuan X; Ren J; Li X; Huang X
    Clin Exp Pharmacol Physiol; 2017 May; 44(5):529-538. PubMed ID: 28135768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visually defining and querying consistent multi-granular clinical temporal abstractions.
    Combi C; Oliboni B
    Artif Intell Med; 2012 Feb; 54(2):75-101. PubMed ID: 22177662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.